NEPAL EXPANSION · KATHMANDU VALLEY
Building a Scalable Preventive Healthcare Platform with Strong Recurring Revenue
Kathmandu · Patan (Lalitpur) · Bhaktapur
Strategic Investment Opportunity for Nepali Investors · 2026
Extra Info · Full Deck
NanoChain Nepal — Investor Deck 2026
The complete 17-slide deck for Nepali investors. Scroll through it here or download a copy to share.
Investor Inquiry
Talk to the founder team
Interested in participating? Share a few details and we'll follow up with the data room, terms and a call.
Investor Q&A
Ask the deck
Have a question about tiers, unit economics, the Valley rollout or the India track record? Our AI-powered assistant answers using only what's in the investor deck, and tells you when something isn't covered.
Your conversation is saved in this browser only.
Executive Summary
Our Investment Proposition
NanoChain brings a proven preventive healthcare subscription platform to Nepal, launching across the three historic cities of the Kathmandu Valley.
The Opportunity
Nepal's Diagnostics Market
Large Out-of-Pocket Spend, Fragmented Supply, Transaction-Led
- Diagnostics in Nepal is overwhelmingly paid out-of-pocket, one test at a time
- Valley labs compete on price, not on patient relationship or retention
- No meaningful annual membership or preventive-care product in the market
- Low lifetime value and no recurring revenue visibility for incumbents
- Rising chronic disease burden in urban Nepal with almost no structured monitoring
- Growing insurance and corporate wellness demand with no organised diagnostics partner
We replace one-time pathology dependency with an annual subscription model.
Track Record
Proven Commercially in India
The Model Is Already Operating — Nepal Is the Next Market
Audited-period revenues from the existing India operation, stated in Indian Rupees.
Initial commercial viability
Continued market validation
Plus INR 5 Cr+ qualified pipeline
Capital in Nepal funds execution speed, distribution density and Valley-wide scale — not unproven product risk.
Business Model
Recurring Revenue Engine
Acquire one institutional partner → onboard thousands of end customers.
Unit Economics
Nepal Subscriber Model
Investor-Grade Financial Profile
Modelled for Kathmandu Valley pricing and cost base. Assumptions to be re-confirmed against launch-quarter actuals.
Kathmandu Valley Proof of Concept
Kathmandu · Patan · Bhaktapur
One Contiguous Metro, Three Cities, Single Hub Economics
Capital for full Valley-scale execution
Active subscribers (12–18 months)
- — Central processing hub in Kathmandu serving all three cities
- — 60+ spoke collection points across Kathmandu, Patan and Bhaktapur
- — 800+ doctors, polyclinics and institutional channel partners
- — Corporate wellness, cooperative and hospital OPD tie-ups across the Valley
NPR 27 Cr ARR · NPR 38–45 Cr total annual revenue · Clear city-level EBITDA visibility
City Expansion
Valley-First, Then National Replication
Scale driven by repeatable operating playbooks, not excessive capex.
Full premium hub with dense spoke network
Light hub plus high-volume partner network
Efficient hub with doctor-led acquisition
Spoke-first franchise and referral model
Revenue by Tier
Investor Selects Speed of Scale
Capital size determines expansion velocity and ownership depth.
FY 2027 revenue ranges are modelled projections, not commitments.
| Tier | Capital | FY 2027 Revenue | Outcome |
|---|---|---|---|
| Entry Tier | NPR 1 Cr – 3 Cr | NPR 4 Cr – 8 Cr | Kathmandu validation + initial spoke activation |
| Growth Tier | NPR 5 Cr – 8 Cr | NPR 10 Cr – 18 Cr | Valley dominance across Kathmandu, Patan and Bhaktapur |
| Scale Tier | NPR 10 Cr – 15 Cr | NPR 20 Cr – 40 Cr | Multi-city rollout + Tier 1 and Tier 2 replication |
| Platform Tier | NPR 20 Cr+ | NPR 50 Cr+ | National infrastructure + insurance + enterprise scale |
Financial Outlook
Nepal Operations — Revenue Scenarios
Practical and Scalable Revenue Projections
Nepal entity only. India revenues are reported separately.
| Year | Base Case | Growth Capital | Platform Scale |
|---|---|---|---|
| FY 2026-27 | NPR 6 Cr | NPR 14 Cr | NPR 30 Cr |
| FY 2027-28 | NPR 12 Cr | NPR 32 Cr | NPR 65 Cr |
| FY 2028-29 | NPR 20 Cr | NPR 55 Cr | NPR 120 Cr |
Investor Confidence
Why Nepali Investors Engage
Revenue visibility precedes valuation expansion.
Strategic Value Drivers
What Builds Enterprise Value
Recurring Healthcare Ownership
The moat is recurring healthcare ownership.
| Traditional Nepali Labs | NanoChain Nepal |
|---|---|
| One-time test transactions | Preventive healthcare membership |
| Pricing competition | Annual recurring revenue model |
| Fragmented customer retention | Customer lifetime expansion |
| No subscription revenue | Institutional partnership channels |
| Low lifetime value | Scalable retention infrastructure |
Beyond Testing
Building the Next Layer of Enterprise Value
From diagnostics operator to data-driven preventive healthcare intelligence platform.
Valuation Scenario
From Operator to Platform
Illustrative scenarios for the Nepal entity. Subject to performance and market conditions.
How to Invest
Flexible Participation Structure
Invest based on your conviction, ownership preference and strategic alignment.
Strategic angels · Follow-on rights
Lead investors & syndicates · Board visibility
Institutional growth · Co-investment rights
Strategic partners · Board seat
Milestone-linked deployment · Structured for disciplined long-term capital alignment
The Thesis
Scalable · Recurring · Defensible · Investable
- — Proven commercial traction in India with existing revenue and an INR 5 Cr+ active pipeline.
- — Validated operating model, ready for accelerated execution across the Kathmandu Valley.
- — NanoCard creates predictable, compounding recurring revenue in Nepali Rupees.
- — Preventive healthcare infrastructure creates long-term defensibility in an underserved market.
- — Capital deployed today accelerates entry at a proven inflection point.
Founder & CEO · NanoChain · NanoCard